文献速递免疫规划妇幼与学校卫生

移民儿童乙肝疫苗接种高覆盖率与慢性乙肝低患病率提示新的补种策略

High coverage of hepatitis B vaccination and low prevalence of chronic hepatitis B in migrant children dictate a new catch-up vaccination strategy.
PubMed 文献 · Vaccine · 2018-06-12

研究前瞻性纳入2014年10月至2017年7月期间新抵达洛桑大学医院的1-18岁移民儿童,这些儿童无既往接种证明并接受单剂乙肝疫苗注射,4-6周后检测乙肝表面抗体。200名儿童中81%出现加强型抗体应答,仅1例(<1%)患慢性乙肝;多因素分析显示较小年龄和城市地区移民是加强型应答的独立决定因素。作者认为疫苗后血清学检测可识别既往免疫者,且该人群慢性乙肝患病率极低。

要点

  • 无接种证明的移民儿童中,单剂乙肝疫苗后81%(161/200)出现加强型抗体应答。
  • 慢性乙肝患病率仅<1%(1例),支持疫苗后血清学检测策略。
  • 较小年龄(每减少1岁OR 1.28)和城市移民(OR 1.16)与加强型应答相关。

核心结论

  • 疫苗后血清学检测可识别本儿科移民人群中既往乙肝免疫的高比例个体。
  • 本研究发现慢性乙肝患病率极低。
  • 无变量能确定性地预测血清学结果。
  • 在疫苗高覆盖率背景下,疫苗后血清学检测是最有效的策略。

研究设计与样本

  • 前瞻性研究,纳入2014年10月至2017年7月在洛桑大学医院新抵达的1-18岁移民儿童和青少年,无既往接种证明并接受单剂乙肝疫苗注射。
  • 共200名儿童纳入分析,中位年龄8.9岁(IQR 4.8-12.9),97名(49%)为女性,124名(62%)来自WHO分类的东地中海区域。
  • 接种后4-6周检测乙肝表面抗体,抗-HBs ≥100 IU/L定义为加强型抗体应答;<100 IU/L者接受额外剂量,<10 IU/L者排除慢性乙肝。

主要发现

  • 161名儿童(81%)出现加强型抗体应答,仅1例(<1%)患慢性乙肝。
  • 多因素分析中,较小年龄(每减少1岁OR 1.28;95%CI 1.05-1.57;p=0.017)和来自城市地区(OR 1.16;95%CI 1.01-1.33;p=0.043)是加强型应答仅有的显著决定因素。

临床怎么用

  • 作者认为疫苗后血清学检测可用于识别既往乙肝免疫的移民儿童。
  • 作者认为在疫苗高覆盖率背景下,疫苗后血清学检测是最有效的策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Worldwide coverage of hepatitis B (HB) vaccination is increasing. This should be considered when determining the best strategy for catch-up HB vaccination in migrant children, who rarely have written proof of past immunizations. This study aimed to estimate HB vaccine protection, chronic HB prevalence and to identify determinants of vaccine protection. METHODS: Newly arrived migrant children at Lausanne University Hospital from October 2014 to July 2017 were prospectively enrolled. Children and adolescents aged 1-18 years were approached for inclusion if they had no proof of past vaccinations and accepted a single dose of injected HB vaccine. HB surface antibody (anti-HBs) serology was performed after 4-6 weeks. Anti-HBs ≥100 IU/L were considered consistent with a booster-type antibody response. Patients with anti-HBs <100 IU/L received additional dose(s) of HB vaccine, after exclusion of chronic HB in children with anti-HBs <10 IU/L. Potential determinants of vaccine response were compared between children with and without booster-type response. RESULTS: Two hundred children were available for analysis. Median age was 8.9 years (IQR 4.8-12.9), and 97 (49%) were female. The majority (n = 124, 62%) came from the region classified by the WHO as eastern Mediterranean. One hundred and sixty-one children (81%) had a booster-type antibody response. Only 1 patient (<1%) had chronic HB. In the multivariate analysis, younger age (OR per decreasing-year, 1.28; 95%CI, 1.05-1.57; p = 0.017) and migration from an urban area (OR 1.16; 95%CI, 1.01-1.33; p = 0.043) were the only significant determinants of booster-type response. CONCLUSION: Post-vaccine serology may be used to identify a high proportion of individuals in our pediatric migrant population with previous immunization for HB. Our study also showed extremely low prevalence of chronic HB. No variable could definitively determine the results of serology. Post-vaccine serology represents the most effective strategy in this context of high vaccine coverage.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fougère Y, El Houss S, Suris JC, et al. High coverage of hepatitis B vaccination and low prevalence of chronic hepatitis B in migrant children dictate a new catch-up vaccination strategy. Vaccine. 2018. PMID: 29907480. doi:10.1016/j.vaccine.2018.06.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。